Yeah not bad, and a whole lot better than what we where getting. Hope we get some hard data, re output etc soon, that is when we will know for sure how good the bouys really are.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025